Filing Impact
Filing Sentiment
Form Type
144
Analyzing...
Voyager Therapeutics Inc
Aug 26, 2025
Voyager to Present at Upcoming Investor Conferences
Feb 24, 2026
[144] Voyager Therapeutics, Inc. SEC Filing
Feb 24, 2026
[144] Voyager Therapeutics, Inc. SEC Filing
Feb 24, 2026
[144] Voyager Therapeutics, Inc. SEC Filing
199.05M
46.30M
Biotechnology
Biological Products, (no Diagnostic Substances)
United States
LEXINGTON